Retains high concentrations of a potent chemotherapeutic drug inside tumors for extended periods. Is injected directly into solid tumors. Is designed to be used as a single therapy or integrated with other cancer therapies. Provides a homogeneous, reliable, and safe delivery system that focuses high concentrations of cisplatin in the tumor but without the concomitant toxicities typically associated with IV administration of cisplatin. Tumors that are visible or accessible by biopsy needle are potential candidates for treatment with IntraDose.
Endoscopic administration allows for treatment of tumors in the esophagus and nasopharynx.
Recent Clinical Results IntraDose is currently being evaluated in advanced clinical trials to treat patients with solid tumors of various histologies, including head and neck cancer and liver cancer. For recent press releases describing clinical trials, click here .